Incross Co.,Ltd. Logo

Incross Co.,Ltd.

A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.

216050 | KO

Overview

Corporate Details

ISIN(s):
KR7216050005
LEI:
Country:
South Korea
Address:
서울특별시 관악구 남부순환로 1926 (경동제약빌딩 5층,8층), 관악구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Incross Co., Ltd. is a digital marketing company specializing in data-driven advertising solutions. The company develops and operates a portfolio of proprietary platforms, including 'Dawin,' a leading video ad network in South Korea, and 'T deal,' an AI-powered commerce service leveraging SK Telecom customer data. Incross also offers 'ASUM,' a big data marketing platform integrating SK Group's advertising businesses, and 'Stellyze,' an AI-based content marketing platform. The firm provides comprehensive services from strategic media planning and campaign execution to performance analysis, supported by its dedicated R&D center and the Incross Data Lab (IDL) for advanced audience insights and targeting.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Related Party Transaction
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 9.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.0 MB
2025-08-14 00:00
Environmental & Social Information
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 2.1 KB
2025-08-05 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.7 KB
2025-08-05 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.7 KB
2025-05-30 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 109.9 KB
2025-05-20 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.2 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.0 MB
2025-05-08 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.2 KB
2025-05-07 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.7 KB
2025-05-07 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.7 KB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 28.0 KB
2025-03-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-18 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 466.7 KB

Automate Your Workflow. Get a real-time feed of all Incross Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Incross Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Incross Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.